Thiopurines best practice

被引：1
|
作者：
Friedman, Antony [1 ,2 ]
机构：
[1] Alfred Hosp, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
INFLAMMATORY-BOWEL-DISEASE; COMBINATION THERAPY; INFLIXIMAB; AZATHIOPRINE; REMISSION;
D O I：
10.1111/jgh.13345
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [31] Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy
    Ong, David E. H.
    Kamm, Michael A.
    Hartono, Juanda Leo
    Lust, Mark
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (10) : 1595 - 1599
  • [32] Optimizing the use of thiopurines in inflammatory bowel disease
    Goel, Rishi M.
    Blaker, Paul
    Mentzer, Alex
    Fong, Steven C. M.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 138 - 146
  • [33] Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy
    Lopez-Palacios, Natalia
    Mendoza, Juan L.
    Taxonera, Carlos
    Lana, Raquel
    Esteban Lopez-Jamar, Jose Miguel
    Diaz-Rubio, Manuel
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (06) : 621 - 625
  • [34] Therapeutic Agents and Patient Characteristics Affecting Metabolism of Thiopurines in Patients with Inflammatory Bowel Disease
    Aizawa, Masato
    Suzuki, Kohei
    Nakajima, Yuki
    Utano, Kenichi
    Tamazawa, Kana
    Ueda, Kenta
    Wada, Jun
    Sato, Kentaro
    Shibukawa, Goro
    Tanaka, Noriko
    Togashi, Kazutomo
    FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2025, 71 (01) : 47 - 55
  • [35] Is There Still a Role for Thiopurines in Crohn's Disease?
    Rogler, Gerhard
    Sandborn, William J.
    GASTROENTEROLOGY, 2013, 145 (04) : 714 - 716
  • [36] A practical guide to the use of thiopurines in oral medicine
    Hullah, E. A.
    Blaker, P. A.
    Marinaki, A. M.
    Escudier, M. P.
    Sanderson, J. D.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2015, 44 (10) : 761 - 768
  • [37] Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease
    Vasudevan, Abhinav
    Parthasarathy, Nina
    Con, Danny
    Nicolaides, Steven
    Apostolov, Ross
    Chauhan, Ayushi
    Bishara, Maria
    Luber, Raphael P.
    Joshi, Neetima
    Wan, Anna
    Rickard, James A.
    Long, Tony
    Connoley, Declan
    Sparrow, Miles P.
    Gibson, Peter R.
    van Langenberg, Daniel R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (07) : 1174 - 1184
  • [38] Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents
    Iborra, Marisa
    Beltran, Belen
    Maroto, Nuria
    Navarro-Cortes, Pablo
    Bosca-Watts, Maia
    Ferrer-Bradley, Isabel
    Garcia-Morales, Natalia
    Saez-Gonzalez, Esteban
    Hinojosa, Joaquin
    Minguez, Miguel
    Nos, Pilar
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (09): : 535 - 543
  • [39] Are We Using and Monitoring Thiopurines and Biologics Optimally?
    Irving, Peter M.
    DIGESTIVE DISEASES, 2014, 32 (04) : 410 - 418
  • [40] Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions
    De Bernardi, Alice
    Bezzio, Cristina
    Puricelli, Michele
    Gilardi, Daniela
    Saibeni, Simone
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
12345